Global /India /Healthcare /Drug Manufacturers - General /HESTERBIO
chevron_leftBack
Hester Biosciences Ltd. logo

Hester Biosciences Ltd.

HESTERBIO
NSE: HESTERBIO Delayed
1,634.20INR -1.3%
17.31 USD
As of 21 June 2026, Hester Biosciences Ltd. has a market cap of $149.71M USD, ranking #22885 globally and #1342 in India. It ranks #2054 in the Healthcare sector, and #741 in the Drug Manufacturers - General industry.
Global Rank
22885
Country Rank
1342
Sector Rank
2054
Industry Rank
741
Key Stats
Market Cap
$149.71MUSD
14.13B INR
Enterprise Value
$172.83MUSD
16.32B INR
Revenue (TTM)
$33.46MUSD
3.16B INR
EBITDA (TTM)
$7.61MUSD
718.13M INR
Net Income (TTM)
$4.34MUSD
409.47M INR
EBITDA Margin
23%
Profit Margin
13%
PE Ratio
34.5
PS Ratio
4.5
PB Ratio
4.0
EV/EBITDA
21.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Rajiv Gandhi open_in_new
Employees
562
Founded
1987
Website
hester.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.3% 10% 26% 15% 2.1% -13%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
HESTERBIO
Hester Biosciences Ltd
ISIN: INE782E01017
Shares Out.:
8.507M1 Shares Float: 3.035M2
TV:
SA:
YF:
GF:
BA:
MS:
1,634.20 INR
Bombay Stock Exchange
MIC: XBOM
524669 (HESTERBIO)
Hester Biosciences Ltd
ISIN: INE782E01017
TV:
SA:
YF:
GF:
BA:
MS:
1,661.05 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hester Biosciences Ltd.

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella abortus, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming aids, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, vitamins, minerals and specialty feed supplements, and various formulations for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides sero-profiling kits, diagnostic labs for poultry flocks, and mastitis control programs for cattle; and manufactures and trades in goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
30K%
39.1
DIVISLAB
$18.38B
1.73T INR
12K%
70.0
$15.17B
1.43T INR
10K%
63.0
$11.73B
1.11T INR
8K%
19.6
MANKIND
$9.87B
931.67B INR
6K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
6K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
509K%
38.1
JNJ
$547.28B
365K%
26.4
ABBV
$360.63B
241K%
97.4
$318.3B
256.25B CHF
213K%
19.9
AZN
$284.64B
215.59B GBP
190K%
27.6
MRK
$274.03B
183K%
15.1
chevron_leftBack